Literature DB >> 19728968

Migraine headache in perimenopausal and menopausal women.

E Anne MacGregor1.   

Abstract

Perimenopause marks a time of change in a woman's hormonal environment, which is apparent from the resultant irregular periods and vasomotor symptoms. These symptoms can start in the early 40s and continue through to the early 50s. Migraine is also affected by hormonal fluctuations, particularly the natural decline in estrogen in the late luteal phase of the menstrual cycle. This effect of estrogen "withdrawal" on migraine appears to become more predominant during perimenopause. Despite the increased prevalence of headache and migraine in women in their 40s, migraine is underdiagnosed in this population. In women attending with symptoms suggestive of perimenopause, it is important to ask about headache symptoms. Once diagnosed, a number of strategies can be used to manage both perimenopausal migraine and menopausal symptoms effectively, with the potential to reduce the associated morbidity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728968     DOI: 10.1007/s11916-009-0065-2

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  49 in total

1.  Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration.

Authors:  B W Somerville
Journal:  Neurology       Date:  1975-03       Impact factor: 9.910

2.  Hormone replacement therapy and headache prevalence in postmenopausal women. The Head-HUNT study.

Authors:  K L Aegidius; J-A Zwart; K Hagen; B Schei; L J Stovner
Journal:  Eur J Neurol       Date:  2007-01       Impact factor: 6.089

3.  Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches.

Authors:  Rossella E Nappi; Grazia Sances; Arianna Sommacal; Silvia Detaddei; Fabio Facchinetti; Silvano Cristina; Franco Polatti; Giuseppe Nappi
Journal:  Menopause       Date:  2006 Sep-Oct       Impact factor: 2.953

4.  Migraine in a specialist menopause clinic.

Authors:  E A MacGregor; D Barnes
Journal:  Climacteric       Date:  1999-09       Impact factor: 3.005

5.  Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study.

Authors:  E A MacGregor; A Frith; J Ellis; L Aspinall; A Hackshaw
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

6.  Prospective analysis of factors related to migraine attacks: the PAMINA study.

Authors:  C Wöber; W Brannath; K Schmidt; M Kapitan; E Rudel; P Wessely; C Wöber-Bingöl
Journal:  Cephalalgia       Date:  2007-04       Impact factor: 6.292

7.  The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test.

Authors:  E M Lichten; J B Lichten; A Whitty; D Pieper
Journal:  Headache       Date:  1996-06       Impact factor: 5.887

8.  Predictability of exogenous hormone effect on subgroups of migraineurs.

Authors:  L Mueller
Journal:  Headache       Date:  2000-03       Impact factor: 5.887

9.  Symptoms in the menopausal transition: hormone and behavioral correlates.

Authors:  Ellen W Freeman; Mary D Sammel; Hui Lin; Clarisa R Gracia; Shiv Kapoor
Journal:  Obstet Gynecol       Date:  2008-01       Impact factor: 7.661

10.  Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women.

Authors:  F Granella; G Sances; C Zanferrari; A Costa; E Martignoni; G C Manzoni
Journal:  Headache       Date:  1993 Jul-Aug       Impact factor: 5.887

View more
  17 in total

1.  Sex matters: evaluating sex and gender in migraine and headache research.

Authors:  B Lee Peterlin; Saurabh Gupta; Thomas N Ward; Anne Macgregor
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

2.  Sex differences in the inflammatory mediator-induced sensitization of dural afferents.

Authors:  N N Scheff; M S Gold
Journal:  J Neurophysiol       Date:  2011-07-13       Impact factor: 2.714

Review 3.  Women and Migraine: the Role of Hormones.

Authors:  Candice Todd; Ana Marissa Lagman-Bartolome; Christine Lay
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-31       Impact factor: 5.081

4.  Migraine history, nonsteroidal anti-inflammatory drug use, and risk of postmenopausal endometrial cancer.

Authors:  Amanda I Phipps; Garnet L Anderson; Barbara B Cochrane; Christopher I Li; Jean Wactawski-Wende; Gloria Y F Ho; Mary Jo O'Sullivan; Polly A Newcomb
Journal:  Horm Cancer       Date:  2012-07-24       Impact factor: 3.869

5.  Evaluation and management of migraine in midlife women.

Authors:  Jelena M Pavlović
Journal:  Menopause       Date:  2018-08       Impact factor: 2.953

Review 6.  Migraine changes the brain: neuroimaging makes its mark.

Authors:  Till Sprenger; David Borsook
Journal:  Curr Opin Neurol       Date:  2012-06       Impact factor: 5.710

Review 7.  Migraine in perimenopausal women.

Authors:  G Allais; G Chiarle; F Bergandi; C Benedetto
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

Review 8.  Estrogen, migraine, and vascular risk.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 9.  Migraine in menopausal women: a systematic review.

Authors:  Patrizia Ripa; Raffaele Ornello; Diana Degan; Cindy Tiseo; Janet Stewart; Francesca Pistoia; Antonio Carolei; Simona Sacco
Journal:  Int J Womens Health       Date:  2015-08-20

10.  Studies on the pathophysiology and genetic basis of migraine.

Authors:  Claudia F Gasparini; Heidi G Sutherland; Lyn R Griffiths
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.